Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) Shares Outstanding (Weighted Average) (2019 - 2025)

Historic Shares Outstanding (Weighted Average) for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to $720.0.

  • Legend Biotech's Shares Outstanding (Weighted Average) rose 2857.14% to $720.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $720.0, marking a year-over-year increase of 2857.14%. This contributed to the annual value of $318.1 million for FY2022, which is 1291.45% up from last year.
  • Latest data reveals that Legend Biotech reported Shares Outstanding (Weighted Average) of $720.0 as of Q3 2025, which was up 2857.14% from $620.0 recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's Shares Outstanding (Weighted Average) ranged from a high of $318.1 million in Q4 2022 and a low of $210.0 during Q2 2024
  • Over the past 4 years, Legend Biotech's median Shares Outstanding (Weighted Average) value was $138.6 million (recorded in 2021), while the average stood at $147.6 million.
  • Per our database at Business Quant, Legend Biotech's Shares Outstanding (Weighted Average) crashed by 9986.69% in 2021 and then surged by 11582417.96% in 2022.
  • Quarter analysis of 4 years shows Legend Biotech's Shares Outstanding (Weighted Average) stood at $281.7 million in 2021, then grew by 12.91% to $318.1 million in 2022, then crashed by 100.0% to $560.0 in 2024, then increased by 28.57% to $720.0 in 2025.
  • Its last three reported values are $720.0 in Q3 2025, $620.0 for Q2 2025, and $560.0 during Q3 2024.